MBX Biosciences, Inc. Common Stock

NASDAQ:MBX

Biotechnology

Healthcare
$53.42 -1.54%

-$0.64 today

Market cap
$2.65B
Beta
0.75
P/E (TTM)
-22.0
EPS (TTM)
-$1.86
52W Low $9.43High $45.85

Volume 0.73M

Average 0.65M

Balance Sheet

Inspect the capital base behind the business.

Assets

$385.14M

FY 2025 · Annual

+43.4% YoY

Liabilities

$15.92M

FY 2025 · Annual

+43.5% YoY

Equity

$369.22M

FY 2025 · Annual

+43.4% YoY

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents24.21M30.52M49.35M75.29M
Short-term Investments18.25M50.15M212.8M298.42M
Net Receivables142K208K682K2.12M
Inventory0000
Other Current Assets84K133K803K861K
Total Current Assets44.21M83.47M267.29M381.54M
Property, Plant & Equipment (Net)842K665K1.2M3.22M
Goodwill0000
Intangible Assets0000
Long-term Investments0000
Tax Assets0000
Other Non-current Assets42K50K50K383K
Total Non-current Assets884K715K1.25M3.61M
Total Assets45.1M84.18M268.54M385.14M
Account Payables976K1.39M5.34M2.98M
Short-term Debt0000
Tax Payables0000
Deferred Revenue0000
Other Current Liabilities1.13M1.37M2.32M4.32M
Total Current Liabilities3.43M3.93M11.05M15.5M
Long-term Debt000424K
Deferred Tax Liabilities0000
Deferred Revenue (Non-current)0000
Other Non-current Liabilities83.95M152.55M42K2K
Total Non-current Liabilities84.27M152.72M42K426K
Total Liabilities87.7M156.65M11.09M15.92M
Common Stock1K1K5K6K
Retained Earnings(43.02M)(75.58M)(137.51M)(224.48M)
Accumulated OCI3K60K55K286K
Other Stockholders Equity0000
Minority Interest0000
Total Equity(42.61M)(72.47M)257.44M369.22M
Total Debt461K324K171K596K
Net Debt(23.75M)(30.2M)(49.18M)(74.69M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$161.7M
Short-term Investments$319.9M
Receivables$3.2M
Other Current$7.9M
Total Current Assets$492.8M
PP&E (Net)$7.6M
Other Non-current$247.0K
Total Non-current Assets$7.9M
Total Assets$500.6M

Analysis

Selected assets total $500.6M for Latest. The largest visible component is Short-term Investments at $319.9M, about 63.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 12, 2026
S-8S-8 filingNov 10, 2026
8-KCurrent reportNov 9, 2026
10-QQuarterly reportNov 9, 2026
4Statement of changes in beneficial ownershipNov 5, 2026

How much cash does MBX have?

MBX Biosciences, Inc. Common Stock (MBX) reported $75.29M in cash and equivalents in fiscal 2025.

How much debt does MBX carry?

MBX Biosciences, Inc. Common Stock (MBX) reported $596,000.00 of total debt, with net debt of -$74.69M.